InSightec Stock
InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery.
Sign up today and learn more about InSightec Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About InSightec Stock
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
Investors
Funding History
| November 2007 | $30.0M |
|---|---|
| December 2012 | $30.9M |
| December 2014 | $59.0M |
| January 2016 | $22.0M |
| December 2017 | $150M |
| March 2020 | $150M |
Management
CFO
Roni Karie
CEO & Chairman
Maurice Ferre, M.D.
CEO and Founder
Kobi Vortman
Press
bioworld - Sep, 16 2023
Insightec secures additional CE mark for Exablate Neuro to treat essential tremorsnewswire - Jan, 4 2023
Insightec to Present at the 41st Annual J.P. Morgan Healthcare Conferencebizjournals - Jul, 7 2022
Insightec wins FDA approval to study novel prostate cancer treatmentprnewswire - Jun, 2 2022
INSIGHTEC APPOINTS NEW MEMBER TO BOARD OF DIRECTORSen - Jan, 4 2022
Insightec cuts SPAC merger valuationfiercebiotech - Dec, 5 2021
FDA clears Insightec's MRI-guided sound wave technology to treat prostate cancerjewishbusinessnews - Oct, 18 2021
Insightec Set for $2 Billion IPOift - Oct, 17 2021
Medical device co Insightec set for SPAC merger at $2b valuationmassdevice - Apr, 7 2021
Insightec raises $136M for incisionless surgery techgeektime - Dec, 21 2020
Philips & InSightec join forces to usher in the future of patient caremassdevice - Dec, 19 2020
Philips, InSightec team up on ultrasound for neurosurgerytechstartups - Nov, 20 2020
Unicorn startup companies 2020: List of top 500 unicorn startups with valuation of $1 Billion+bit - Jul, 14 2020
Insightec wins Medicare coverage for incisionless neurosurgery platformnanalyze - Jun, 28 2020
Ultrasound Technology for 5 Types of Medical Conditionsmassdevice - Mar, 13 2020
Insightec raises another $150m for incisionless neurosurgery platformprnewswire - Mar, 7 2020
INSIGHTEC Investment Up to $150 Million Led by Koch Disruptive Technologiesmedcitynews - Mar, 7 2020
Insightec raises $150M for incisionless surgeryen - Jan, 5 2020
Koch seen as the investor injecting $150m into Insightecen - Dec, 27 2019
Elbit Medical agrees to sell Insightec stake for $102men - Dec, 17 2019
Elbit Medical signs MoU to sell Insightec stake for NIS 128men - Dec, 17 2019
Elbit Medical signs MoU to sell Insightec stake for NIS 128mbusinessinsider - Dec, 7 2019
This time it actually is brain surgeryen - Sep, 17 2019
Elbit Medical negotiating early exit from Insightecmedcitynews - Jul, 12 2019
Insightec wants to usher in a new era of incisionless surgeryprnewswire - Jul, 11 2019
INSIGHTEC Receives FDA Approval and CE Mark for Exablate Neuro With GE SIGNA Premier MR Systemmassdevice - Dec, 21 2018
FDA expands indication for Insightec’s Exablate Neuro in Parkinson’sbioportfolio - Dec, 13 2018
InSightec Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750en - Nov, 18 2018
Insightec CEO confident of $30-50 billion exiten - Nov, 18 2018
Insightec CEO confident of $30-50 billion exitmassdevice - Sep, 27 2018
FDA green-lights Insightec’s Exablate for use with select Seimens MRI scannersen - Sep, 27 2018
FDA approves Insightec-Siemens neurology surgery platformbusinesswire - Jun, 23 2018
CooperKatz Welcomes Three New Clients Transforming Lives Through Technologyen - Jun, 21 2018
INSIGHTEC's Focused Ultrasound Earns Positive NICE Guidance for Treatment of Essential Tremormassdevice - Jun, 6 2018
Insightec wins Medicare coverage in 10 statesprnewswire - Jun, 5 2018
INSIGHTEC's MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicaremassdevice - May, 19 2018
Insightec seeks Parkinson’s indication in Japan for Exablate Neuroprnewswire - May, 14 2018
INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson's Diseasecnbc - May, 10 2018
Ultrasound targeting the brain is poised to revolutionize the treatment for Parkinson’s diseaseprnewswire - May, 3 2018
Focused Ultrasound Extends Its Focus: INSIGHTEC Initiates Parkinson's Disease Study With First Patient Treated With Incisionless Brain Surgerynews-medical - Apr, 27 2018
Parkinson's disease pivotal trial treats first patient using focused ultrasoundprnewswire - Apr, 13 2018
Exablate Neuro From INSIGHTEC Takes Top Honor at Edison Awardsinsightec - Feb, 25 2018
KOCH DISRUPTIVE TECHNOLOGIES TO LEAD $150 MILLION INVESTMENT OF INSIGHTECcrowdfundinsider - Feb, 23 2018
OurCrowd, Along with Three of its Portfolio Companies, Recognized as World’s Most Innovative Companiesprnewswire - Feb, 21 2018
Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Servicesprnewswire - Jan, 31 2018
INSIGHTEC Closes $150 Million Series E Financingprnewswire - Jan, 29 2018
Virginia Tech Carilion Research Institute Partners With INSIGHTEC on Research Program to Develop Treatments for Brain Disorders With Innovative Focused Ultrasound Technologyglobes - Dec, 14 2017
Koch Industries leading $75-150m round in Insightecprnewswire - Dec, 14 2017
Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTECprnewswire - Dec, 2 2017
INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson's Diseasemassdevice - Nov, 30 2017
Insightec wins FDA nod for Exablate Neuro glioblastoma trialprnewswire - Nov, 29 2017
Insightec: The Taiwanese Food and Drug Administration (TFDA) Approved Exablate Neuro for the Treatment of Essential Tremorprnewswire - Nov, 28 2017
FDA Approves First Study of INSIGHTEC's Exablate Neuro to Open the Blood-Brain Barrier in Glioblastoma Patientsmassdevice - Nov, 12 2017
FDA approves pivotal trial for Insightec’s Exablate Neuro in Parkinson’sprnewswire - Nov, 5 2017
INSIGHTEC's Exablate Neuro Named Best Medical Technology at Esteemed Prix Galien Awards 2017prnewswire - Aug, 16 2017
INSIGHTEC Announces Expanded Reach of MR-Guided Focused Ultrasoundmassdevice - May, 26 2017
Insightec wins FDA nod for Exablate Neuro for use with 1.5T MRInocamels - Nov, 11 2016
GE Healthcare Invests $13.8m In ‘Insightec’cbinsights - Oct, 26 2016
US Commands Majority Of Medical Device Startup Deals, With Israel And UK As Runner-Upsmassdevice - Oct, 26 2016
InSightec names Ferré for board, raises $59m for ExAblate fibroid device | Medtech funding for the week of December 15, 2014massdevice - Sep, 29 2015
InSightec names Ferré for board, raises $59m for ExAblate fibroid device | Medtech funding for the week of December 15, 2014massdevice - Sep, 29 2015
InSightec names Ferré for board, raises $59m for ExAblate fibroid device | Medtech funding for the week of December 15, 2014massdevice - Sep, 29 2015
Zimmer and Biomet update on their mega-mergermassdevice - Sep, 29 2015
Medigus secures $5.6M in funding, reveals positive outcomes from study of its MUSE surgical endostapling device | Medtech funding for the week of September 15, 2014massdevice - Sep, 29 2015
Aethlon plans IDE, slims losses on Q1 reportfinsmes - Sep, 29 2015
InSightec Raising $50M in Series D Fundingxconomy - Sep, 29 2015
InSightec Receives $50,000,000 Series D Fundingmassdevice - Sep, 29 2015
InSightec seeks $50M for ultrasound tumor therapyfiercemedicaldevices - Sep, 29 2015
How did Israel become a hotbed for medical devices?massdevice - Sep, 29 2015
Funding: InSightec raises $12.5M from Chinese backersmassdevice - Sep, 29 2015
Toshiba contests Reuters report on expected lossesmassdevice - Sep, 29 2015
InSightec names Ferré for board, raises $59m for ExAblate fibroid device | Medtech funding for the week of December 15, 2014fastcompany - May, 21 2015
Brain Surgery Without the Messventurebeat - May, 20 2015
Life sciences briefing: Thursday, Nov. 29, 2007 | VentureBeat | News | by David P. Hamiltonfiercemedicaldevices - Dec, 16 2014
GE-backed InSightec gets $59M for noninvasive surgical tool, adds ex-Mako CEO to boardEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
